Document Detail

Effects of age on outcome in the SENTIS trial: better outcomes in elderly patients.
MedLine Citation:
PMID:  23075518     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Increasing age is associated with poor outcome after stroke. The Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke (SENTIS) trial explored the augmentation of collateral circulation to the ischemic penumbra as a novel approach to stroke treatment. The aim of this post hoc analysis was to examine the effect of age on outcomes in the SENTIS trial.
METHODS: Using data from the randomized controlled SENTIS trial, we explored outcomes of cerebral blood flow augmentation using the NeuroFlo™ device in patients categorized by age strata at 70 and 80 years. We evaluated outcomes of overall serious adverse event (SAE) and intracerebral hemorrhage (ICH) rates, freedom from all-cause and stroke-related mortality, and independent functional outcome as defined by the modified Rankin Scale score (mRS ≤2).
RESULTS: The SENTIS as-treated cohort included 251 patients ≥70 years and 107 patients ≥80 years. Elderly SENTIS patients included a higher percentage of women and Caucasians than the younger group. Patients in the older group more frequently had vascular risk factors including hypertension, previous stroke, transient ischemic attacks and atrial fibrillation. However, baseline risk-factor profile, stroke severity, and time to randomization did not differ between the treated and nontreated elderly patients. The older patients treated with NeuroFlo had significantly higher chances for survival and for obtaining an independent functional state (mRS ≤2) compared with those who were not treated. Rates of SAEs and ICHs did not differ between the treatment groups.
CONCLUSIONS: NeuroFlo treatment is safe and results in better outcomes for elderly patients. This may be the result of recruitment and support of already existing collateral systems in these patients.
Ronen R Leker; Carlos Molina; Kevin Cockroft; David S Liebeskind; Mauricio Concha; Ashfaq Shuaib; Peter Paul De Deyn; W Scott Burgin; Rishi Gupta; William Dillon; Hans-Christoph Diener
Related Documents :
21035698 - Apache iii score on icu admission predicts hospital mortality after open thoracoabdomin...
8085458 - Kawasaki disease presenting with disseminated intravascular coagulation: report of one ...
23921578 - Safety and effectiveness of microvascular decompression for the treatment of hemifacial...
16171578 - Mid- and long-term device migration after endovascular abdominal aortic aneurysm repair...
22211038 - Evaluation of effect and comparison of superoxidised solution (oxum) v/s povidone iodin...
18574278 - The primary and secondary prevention of coronary artery disease: american college of ch...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2012-10-11
Journal Detail:
Title:  Cerebrovascular diseases (Basel, Switzerland)     Volume:  34     ISSN:  1421-9786     ISO Abbreviation:  Cerebrovasc. Dis.     Publication Date:  2012  
Date Detail:
Created Date:  2012-11-22     Completed Date:  2013-04-24     Revised Date:  2014-08-27    
Medline Journal Info:
Nlm Unique ID:  9100851     Medline TA:  Cerebrovasc Dis     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  263-71     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 S. Karger AG, Basel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Cerebral Hemorrhage / therapy*
Middle Aged
Risk Factors
Stroke / therapy*
Treatment Outcome
Young Adult
Grant Support

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Uterine Endometrial Carcinoma: 10 Years' Experience with Long-Term Follow-Up at a Single Korean Inst...
Next Document:  Design of optimal stimulation patterns for neuronal ensembles based on Volterra-type hierarchical mo...